Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection
出版年份 2021 全文链接
标题
Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection
作者
关键词
-
出版物
ANNALS OF SURGICAL ONCOLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-09-19
DOI
10.1245/s10434-021-10775-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era
- (2021) Devarati Mitra et al. ANNALS OF SURGICAL ONCOLOGY
- Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy trial II (MSLT‐2)
- (2021) Kristy Kummerow Broman et al. CANCER
- Use of Completion Lymph Node Dissection for Sentinel Lymph Node-Positive Melanoma
- (2020) Joshua N. Herb et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy
- (2020) Norma E. Farrow et al. ANNALS OF SURGICAL ONCOLOGY
- Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MLST-II: Multi-Institutional Propensity Score Matched Analysis
- (2020) Kristy K. Broman et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Current management of patients with melanoma who are found to be sentinel node‐positive
- (2019) Amanda A. G. Nijhuis et al. ANZ JOURNAL OF SURGERY
- The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care
- (2018) Emily Z. Keung et al. Expert Review of Anticancer Therapy
- Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
- (2018) Alexander M.M. Eggermont et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
- (2017) Jeffrey Weber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
- (2017) Mark B. Faries et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma
- (2017) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- SPECT/CT Improves Detection of Metastatic Sentinel Lymph Nodes in Patients with Head and Neck Melanoma
- (2016) Brandon C. Chapman et al. ANNALS OF SURGICAL ONCOLOGY
- Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial
- (2016) Ulrike Leiter et al. LANCET ONCOLOGY
- Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial
- (2015) Alexander M M Eggermont et al. LANCET ONCOLOGY
- Final Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma
- (2014) Donald L. Morton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sentinel Node Tumor Burden According to the Rotterdam Criteria Is the Most Important Prognostic Factor for Survival in Melanoma Patients
- (2008) Alexander C. J. van Akkooi et al. ANNALS OF SURGERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started